Function and Therapeutic Development of Apotransferrin

@article{Parkkinen2002FunctionAT,
  title={Function and Therapeutic Development of Apotransferrin},
  author={Jaakko Parkkinen and Leni von Bonsdorff and Freja Ebeling and Leila Sahlstedt},
  journal={Vox Sanguinis},
  year={2002},
  volume={83}
}
Characteristics of transferrin Schade and Caroline discovered more than 50 years ago that specific iron-binding proteins in serum and egg white inhibited the growth of certain bacteria. They concluded that the proteins bound iron so tightly that the bacteria were unable to obtain a sufficient amount of iron for growth. The iron-binding protein in serum was identified as transfemn (Schade & Caroline 1946, Holmberg & Laurel1 1947). Human transferrin is a single polypeptide chain containing 679… Expand

Topics from this paper

Expression, purification, and characterization of authentic monoferric and apo-human serum transferrins.
TLDR
Improvements over the previous protocol include: (1) addition of butyric acid at a level of 1mM which leads to a substantial increase in protein production (as much as a 65% increase compared to control cells); and (2) elimination of an anion exchange column prior to isolation on a Qiagen Ni-NTA column which makes purification of the His-tagged constructs faster and therefore more efficient. Expand
Purification and functional characterization of serum transferrin from Nile tilapia (Oreochromis niloticus)
TLDR
The results of this study indicated that OnTF is likely to involve in innate immunity to play a role in host defense against bacterial infection in Nile tilapia. Expand
Exploring the molecular interactions of Galantamine with human Transferrin: In-silico and in vitro insight
Abstract The iron transporter protein, Transferrin (Tf), is a glycoprotein that binds and mediates the Iron (Fe) transport through blood plasma. It has a significant role in transporting Fe in theExpand
Iron chelation in chemotherapy.
  • E. Weinberg
  • Biology, Medicine
  • Advances in applied microbiology
  • 2003
TLDR
The way accumulation of excessive amounts of iron results in the loss of tissue and organ functions is discussed, and the development of Tf and Lf as pharmaceuticals is discussed. Expand
A simple method for obtaining transferrins from human plasma and porcine serum: preparations and properties.
TLDR
PTf was similar to hTf in physical and chemical characteristics, which gave a hint that pTf could substitute for hT f in some kinds of researches, such as using hTF as a carrier in drug targeting system. Expand
Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
TLDR
The in vitro antitubercular assay result showed that the inhibitory activity of the parent drug was conserved in both the conjugates, which were effective against intracellular Mtb H37Rv and were devoid of cytotoxic effect at therapeutic concentration. Expand
A Review of Properties, Delivery Systems and Analytical Methods for the Characterization of Monomeric Glycoprotein Transferrin
TLDR
Both physicochemical and pharmacokinetics transferrin characteristics, the aspects of iron transport after interaction with transferrin, the development of transferrin targeted-nanoparticles are revised, highlighting both their composition, synthesis methods and in vitro/in vivo evaluation. Expand
Therapeutic potential of iron chelators in diseases associated with iron mismanagement
  • E. Weinberg
  • Chemistry, Medicine
  • The Journal of pharmacy and pharmacology
  • 2006
TLDR
A variety of low molecular mass iron chelators are being used/tested to treat whole body iron loading, and specific diseases for which the metal is a known or suspected risk factor. Expand
Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity.
TLDR
It is shown that transferrin has promising therapeutic potential in a wide variety of conditions and can correct anemia by modulating the amount of iron that is available for erythropoiesis and to prevent the toxic effects of free iron. Expand
Transferrin Saturation: A Body Iron Biomarker.
TLDR
Beyond its usual clinical use, an emerging body of evidence has linked TSAT levels to major clinical outcomes such as cardiovascular mortality, which has the potential to extend the utility of TSAT index to risk stratification and prognostication. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 66 REFERENCES
The Structural Mechanism for Iron Uptake and Release by Transferrins
  • M. Hirose
  • Chemistry, Medicine
  • Bioscience, biotechnology, and biochemistry
  • 2000
TLDR
Domain-opened structures with the coordinated Fe3+ by the two tyrosine residues are demonstrated in fragment and intact forms, and their functional implications as a possible intermediate for iron uptake and release are discussed. Expand
Development of a pharmaceutical apotransferrin product for iron binding therapy.
TLDR
The development of a human plasma-derived apotransferrin product for iron binding therapy is described, which has proved safe and well tolerated in early clinical trials inIron binding therapy. Expand
Molecular structure of serum transferrin at 3.3-A resolution.
TLDR
Mapping of the intron/exon splice junctions onto the molecule provides some topological evidence in support of the putative secondary role for transferrin in stimulating cell proliferation. Expand
Non‐transferrin‐bound iron and cellular toxicity
  • G. Anderson
  • Medicine
  • Journal of gastroenterology and hepatology
  • 1999
TLDR
Non-transferrin-bound iron assumes greatest clinical importance in various iron-loading disorders because it can exceed the body’s capacity to sequester it in a relatively harmless protein-bound form. Expand
The significance of iron in infection.
  • J. Bullen
  • Biology, Medicine
  • Reviews of infectious diseases
  • 1981
TLDR
Iron-binding proteins transferrin and lactoferrin appear to be essential for the bactericidal function of polymorphonuclear leukocytes against Pseudomonas aeruginosa and Liberation of heme compounds can enhance clinical infections. Expand
Iron-binding antioxidant potential of plasma albumin.
TLDR
The iron-binding capacity of albumin was found to be substantial, and albumin inhibited lipid peroxidation in a concentration-dependent manner in both systems used. Expand
The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.
TLDR
A simple method for NTBI determination is developed, which operates in a 96-well enzyme-linked immunosorbent assay format with sensitivity comparable to that of previous assays, and could provide a useful index of iron status during chelation and supplementation treatments. Expand
Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin.
TLDR
It is established that NTA is the optimal ligand to chelate the different forms of NTBI present in sera and can be adopted for utilization in the NTBI assay. Expand
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells.
TLDR
Iron uptake by mammalian cells is mediated by the binding of serum Tf to the TfR, and recent work has suggested that the short-lived messenger molecule, NO, can affect cellular Fe metabolism via its interaction with IRP1. Expand
Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays.
TLDR
The chelating agent 1,10-phenanthroline degrades DNA in the presence of copper ions, O 2 , and a suitable reducing agent by a mechanism known to involve oxygen radicals, probably •OH. Expand
...
1
2
3
4
5
...